Back to Awarded Treatment Trials


Awarded Trial: 08TGF-1257

Grant ID

08TGF-1257

Illness

Schizophrenia

Primary Drug/Intervention

Cannabidiol

Primary Dosage

800 mg/day

Secondary Drug Intervention

N/A

Secondary Dosage

N/A

Other Drug/Intervention

N/A

Other Dosage

N/A

Status

Enrolling

Investigator

Leweke

Sample Size

74

Duration of Study Period for Each Subject

10 days

Outcome Measurements

Pharmacokinetic and drug interaction profile of cannabidiol in combination with certain second generation antipsychotics (serum level; cognitive performance on BACS; side effects).

Results

N/A

Publication

N/A

Link

N/A

PI Name

F. Markus Leweke

Degree

MD

Center

Central Insitute of Mental Health

Institution

Ruprecht-Karls-University of Heidelberg

Address

J5

City or Town

Mannheim

State or Province

N/A

Zip or Postal Code

68159

Country

Germany

Email Address

leweke@ecnp.net